MDX: Promising Treatment for Inattentive ADHD?

A new medication has researchers paying close attention to its potential to improve focus and cognition in people with inattentive ADHD.

There may be hope on the horizon for those diagnosed with Predominantly Inattentive ADHD. A drug called Metadoxine Extended Release (MDX) — developed by Alcobra, a biopharmaceutical company focused on developing new medications to help patients...